Thomson Reuters to Provide Mircromedex Drug Information Solutions to Allina Health System
Ann Arbor, MI, — Thomson Reuters, a global provider of information for healthcare professionals, today announced that the Allina Health System has selected Micromedex as their drug information vendor. The decision came after a month-long rigorous evaluation of drug information systems, in which Micromedex was rated higher than any other competitor.
“Our clinicians were clear about their choices,” said Michael Shrift, CMIO at Allina Health System. “The new Micromedex 2.0 interface makes finding answers easier. We’re confident the patient care we provide will always be based on the best evidence available.”
Allina Health System clinicians rated Micromedex against other drug information systems based their ability to answer key clinical questions, ease of use, content quality, and overall satisfaction with each system. Micromedex was the winner.
“When evaluating, we looked at typical and also unusual clinical scenarios, such as whether the treatment of amitriptyline toxicity should include hemodialysis to enhance elimination,” said Brenda Nelson, Pharmacy Systems Coordinator for Allina. “For each test, Micromedex provided the best answer, quickly.”
The four-year agreement provides Allina Health System clinicians point-of-care access to evidence-based clinical information through Micromedex® from Thomson Reuters.
“Allina Health System’s choice was driven by their clinicians, confirming the importance of quality clinical information to the clinical community,” said Thomas Heglund, executive vice president at Thomson Reuters. “Micromedex contains the most clinically accurate, relevant, and consistent information on the market. Because our clinicians complete extensive evaluation and synthesis of the literature, vetting information across multiple content areas, Allina Health System clinicians will know they are making the most informed decisions possible in their effort to practice evidence-based healthcare.”
In addition to web-based access with Micromedex 2.0, and tailored integration with most hospital information systems, Micromedex has been optimized to work with the Safari and Opera Mini browsers for use wtih BlackBerry® smartphones, Android-based phones, or any device with 3G or Wi-Fi connectivity. To date, more than a quarter million clinicians have downloaded the Micromedex Dug Information Application to their iPhone®, iPad™, and iPod® touch devices. For more information, visit www.micromedex.com.
About Allina Health System
Allina is a not-for-profit network of hospitals, clinics and other health care services, providing care throughout Minnesota and western Wisconsin.
About Thomson Reuters
Thomson Reuters is the world’s leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world’s most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.